AlphaFold predicted structure
F12 · P00748

Mean pLDDT
76.3/ 100
Confident
615 residues
Confidence breakdown
- Very high(≥ 90)40%
- Confident(70–90)30%
- Low(50–70)12%
- Very low(< 50)18%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
coagulation factor XII
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Bleeding and platelet disorders
BOTH monoallelic and biallelic, autosomal or pseudoautosomalCOVID-19 research
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedInherited bleeding disorders
BOTH monoallelic and biallelic, autosomal or pseudoautosomalPrimary immunodeficiency or monogenic inflammatory bowel disease
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedVascular skin disorders
BOTH monoallelic and biallelic, autosomal or pseudoautosomalcongenital factor XII deficiency
hereditary angioedema type 3
Reduced factor XII activity
hereditary angioedema
peptic ulcer disease
angioedema
flatulence
serum lipopolysaccharide activity
coronary artery calcification
Hyperbilirubinemia
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Coagulation factor XII
Factor XII is a serum glycoprotein that participates in the initiation of blood coagulation, fibrinolysis, and the generation of bradykinin and angiotensin. Prekallikrein is cleaved by factor XII to form kallikrein, which then cleaves factor XII first to alpha-factor XIIa and then trypsin cleaves it to beta-factor XIIa. Alpha-factor XIIa activates factor XI to factor XIa (PubMed:2019570, PubMed:21304106, PubMed:8427954)
F12 · P00748

Mean pLDDT
76.3/ 100
Confident
615 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0